University Of California, San Francisco

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Virtual Intervention for Lung Cancer

Not Applicable

Withdrawn

Conditions: Lung Neoplasms

Interventions: Behavioral: Videos
Behavioral: Virtual experience

First Posted Date: 2012-09-13

Last Posted Date: 2018-10-11

Lead Sponsor: University of California, San Francisco

Registration Number: NCT01684696

Locations: 🇺🇸
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States

Occupational Therapy-Based Cognitive Rehabilitation of Cocaine Abusers: A Pilot Study

Not Applicable

Completed

Conditions: Cocaine Use Disorder
Mild Cognitive Impairment, So Stated

Interventions: Behavioral: Psychoeducation/games
Behavioral: Occupational therapy-based cognitive rehabilitation

First Posted Date: 2012-09-12

Last Posted Date: 2019-07-01

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 50

Registration Number: NCT01684293

Locations: 🇺🇸
University of California, San Francisco & San Francisco Veterans Affairs Medical Center, San Francisco, California, United States

Effect of Genetic Variation in the Transporter OCT2, MATE1 and MATE2-K on the PKPD of Metformin

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Metformin

First Posted Date: 2012-09-10

Last Posted Date: 2014-07-02

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 41

Registration Number: NCT01681680

Effect of Genetic Variants in MATE1 and OCT3 on the Pharmacodynamics of Metformin in African Americans

Phase 1

Completed

Conditions: Healthy
Type 2 Diabetes Mellitus

Interventions: Drug: Metformin

First Posted Date: 2012-09-10

Last Posted Date: 2014-10-23

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 33

Registration Number: NCT01681693

Locations: 🇺🇸
San Francisco General Hospital, San Francisco, California, United States

Study of Left Atrial Appendage Closure in Patients With Atrial Fibrillation - III

Phase 4

Withdrawn

Conditions: Atrial Fibrillation

Interventions: Device: LARIAT Suture Delivery Device and Accessories

First Posted Date: 2012-09-07

Last Posted Date: 2013-02-25

Lead Sponsor: University of California, San Francisco

Registration Number: NCT01680757

Locations: 🇺🇸
University of Kansas Hospital and Medical Center, Kansas City, Kansas, United States
🇺🇸
University of California, San Francisco, San Francisco, California, United States
🇵🇱
John Paul II Hospital, Krakow, Poland

and more 9 locations

The Effect of Therapeutic Hypothermia on Deceased Donor Renal Graft Outcomes - a Randomized Controlled Trial From the Region 5 Donor Management Goals Workgroup

Not Applicable

Completed

Conditions: Renal Function
Deceased Organ Donor
Mild Hypothermia

Interventions: Other: Hypothermia

First Posted Date: 2012-09-07

Last Posted Date: 2014-12-04

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 370

Registration Number: NCT01680744

Locations: 🇺🇸
University of California San Francisco, San Francisco, California, United States

Lessening Incontinence by Learning Yoga

Not Applicable

Completed

Conditions: Urinary Incontinence
Stress Urinary Incontinence
Urge Urinary Incontinence
Over Active Bladder

Interventions: Other: Yoga Therapy Program

First Posted Date: 2012-08-24

Last Posted Date: 2013-01-17

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 20

Registration Number: NCT01672190

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Meditation for Depression

Not Applicable

Completed

Conditions: Depression

Interventions: Behavioral: Central Meditation and Imagery Therapy

First Posted Date: 2012-08-23

Last Posted Date: 2021-01-13

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 13

Registration Number: NCT01671436

Locations: 🇺🇸
UCLA Semel Institute, Los Angeles, California, United States

Primary Care-Based Interventions to Reduce Alcohol Use Among HIV Patients

Not Applicable

Completed

Conditions: Alcoholism
HIV
Acquired Immunodeficiency Syndrome
Substance-Related Disorders
Alcoholic Intoxication

Interventions: Other: Usual Care
Behavioral: Motivational Interviewing
Behavioral: Email Feedback

First Posted Date: 2012-08-23

Last Posted Date: 2018-10-10

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 614

Registration Number: NCT01671501

Locations: 🇺🇸
Kaiser Permanente Northern California San Francisco Medical Center; 2238 Geary Blvd, San Francisco, California, United States

Sirolimus With Cyclophosphamide and Topotecan for Pediatric/Adolescent Relapsed and Refractory Solid Tumors

Phase 1

Completed

Conditions: Childhood Solid Tumor
Malignant Solid Tumor

Interventions: Drug: Sirolimus, Cyclophosphamide, Topotecan

First Posted Date: 2012-08-22

Last Posted Date: 2017-06-21

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 21

Registration Number: NCT01670175

Locations: 🇺🇸
UCSF Benioff Children's Hospital, San Francisco, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy